Three years into the Covid-19 pandemic, few Americans are rolling up their sleeves to get a Covid vaccine. Only 15.7% of U.S. adults had received the newest Covid shots from Pfizer , Moderna and Novavax as of Nov. 18, according to the latest data from the Centers for Disease Control and Prevention. Those jabs, some of which won approval in mid-September, are designed to target the omicron subvariant XBB.1.5. “Here’s the bottom line: COVID-19 vaccine uptake is lower than we’d like to see, and most people will be without the added protection that can reduce the severity of COVID-19,” the...